Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed; the core change is the new revision.
    Difference
    0.3%
    Check dated 2025-09-14T18:45:57.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-07T13:09:54.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to include new resources and information related to Acute Myeloid Leukemia, while some previous content has been removed, including older references to related diseases and treatments.
    Difference
    4%
    Check dated 2025-08-31T06:20:04.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    1.0%
    Check dated 2025-08-24T03:11:17.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    1%
    Check dated 2025-08-16T22:11:56.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-09T17:10:36.000Z thumbnail image

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.